BridgeMD
New treatment option for Incomplete Spinal Cord Injury (SCI)
Official title Effect of Hybrid Functional Electrical Stimulation and Augmented Reality-Based Gait Training on Gait Parameters Among Incomplete Spinal Cord Injury Patients
ClinicalTrials.gov ID: NCT07263581
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether combining Functional Electrical Stimulation (FES) with Augmented Reality (AR)-based gait training can improve walking ability in individuals with incomplete spinal cord injury (SCI). The study aims to identify the most effective rehabilitation approach for enhancing gait performance and functional independence among these patients.
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Diagnosed with incomplete spinal cord injury (ASIA Impairment Scale C or D)
- Neurological level of injury between T10 and L2
- Aged 18 to 45 years
- Medically stable with no acute complications
- Able to walk with or without assistive devices
You likely can't join if
- Severe spasticity or contractures in the lower limbs
- Significant pain or joint instability in the lower limbs
- Presence of other neurological (e.g., stroke, multiple sclerosis) or musculoskeletal disorders
- Open skin lesions or ulcerations
- History of fractures or orthopedic surgery in the lower limbs
- Severe cardiovascular conditions
See the full eligibility criteria
- Diagnosed with incomplete spinal cord injury (ASIA Impairment Scale C or D)
- Neurological level of injury between T10 and L2
- Aged 18 to 45 years
- Medically stable with no acute complications
- Able to walk with or without assistive devices
- Cognitively intact
- Capable of providing written informed consent
- Stable physical and emotional health
- No history of seizures
- No major urinary or bowel dysfunction
- Severe spasticity or contractures in the lower limbs
- Significant pain or joint instability in the lower limbs
- Presence of other neurological (e.g., stroke, multiple sclerosis) or musculoskeletal disorders
- Open skin lesions or ulcerations
- History of fractures or orthopedic surgery in the lower limbs
- Severe cardiovascular conditions
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.